T. Gajewski

Immunology · 2004–2019

A researcher in the Science corpus: 19 papers; trusts 9 researchers and is trusted by 20 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 244 citations into it; #174 of 2,160 by trust here, #63 by citations
• Oncology — 174 citations into it; #158 of 1,698 by trust here, #74 by citations
• Molecular Biology — 155 citations into it
• Genetics — 36 citations into it

Whom T. Gajewski trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. S. Rosenberg
2. M. Dudley
3. S. Spranger
4. I. Ivanov
5. D. Speiser

Who trusts T. Gajewski overall

1. G. Barber
2. Daniel S. Chen
3. S. Spranger
4. D. Thommen
5. A. Schoenfeld
6. I. Mellman
7. Russell W. Jenkins
8. W. Zou
9. R. Noy
10. Guocan Wang

Papers from T. Gajewski's perspective

Ordered by how strongly the researchers T. Gajewski trusts endorse each paper. Same corpus, a different order for every researcher.

1. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
2. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. (Science)
3. Safety and clinical activity of combined PD-1 (nivolumab) and CTLA-4 (ipilimumab) blockade in advanced melanoma patients (New England Journal of Medicine)
4. Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment (Cancer Research)
5. Natural innate and adaptive immunity to cancer. (Annual Review of Immunology)
6. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma (Proceedings of the National Academy of Sciences of the United States of America)
7. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. (Advances in Immunology)
8. Cancer immunoediting: from immunosurveillance to tumor escape (Nature Immunology)
9. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells (Journal of Experimental Medicine)
10. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. (Journal of Clinical Oncology)

Their papers

• Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy (2015) — 3,508 citations
• The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients (2018) — 2,669 citations
• Loss of PTEN promotes resistance to T cell-mediated immunotherapy (2015) — 1,336 citations
• STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors (2014) — 1,698 citations
• STING-dependent Cytosolic DNA Sensing Promotes Radiation-induced Type I interferon-dependent Antitumor Immunity in Immunogenic Tumors (2014) — 1,896 citations
• The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies (2018) — 662 citations
• Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study. (2019) — 760 citations
• Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy (2017) — 1,415 citations
• Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy (2017) — 1,222 citations
• Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity (2015) — 2,500 citations
• Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity (2015) — 1,351 citations
• Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells (2013) — 1,648 citations
• Innate and adaptive immune cells in the tumor microenvironment (2013) — 3,825 citations
• Cancer classification using the Immunoscore: a worldwide task force (2012) — 795 citations
• Cancer immunotherapy (2012) — 906 citations
• Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells (2011) — 1,090 citations
• Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment (2009) — 1,037 citations
• Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy (2005) — 621 citations
• PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells (2004) — 757 citations